LTS Lohmann Therapie-Systeme AG
LTS expands its CDMO capabilities with the acquisition of Renaissance Lakewood
Andernach (ots) - LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading pharmaceutical technology company today announces the acquisition of Renaissance Lakewood, LLC (“Renaissance”), a US-based contract development and manufacturing organization (CDMO) specializing in nasal sprays and sterile dosage forms. With the acquisition, Renaissance facilities will become ...
mehr